News | January 20, 2022
Green chemistry approaches to synthesis could make a big difference to pharma product outputs
Bio-catalysis and Electro-catalysis emerge as most preferred green chemistry technologies
Bio-catalysis and Electro-catalysis emerge as most preferred green chemistry technologies
Dr Woler joins Sygnature Discovery after the company received significant investment from Five Arrows Principal Investments, the European corporate private equity arm of Rothschild & Co, in 2021
The company has 271 cumulative ANDA filings with USFDA of which 243 ANDAs have been approved and 28 are pending approval
The long-term partnership aims to make fermentation-based biotin available for the full range of relevant applications as a sustainable, non-chemical, European-sourced alternative
Simulated Moving Bed (SMB) technology is a highly engineered process for implementing chromatographic separation
Despite the challenges of pandemic disruptions, drug developers advance promising therapies for conditions, including Alzheimer's, diabetes and asthma
Intox is a GLP certified pre-clinical contract research organization with its test facilities in Pune
The license agreement grants Dr. Reddy's the exclusive rights to commercialize the proposed biosimilar in select countries in Latin America and Southeast Asia
In 2019, diabetes was the ninth leading cause of death with an estimated 1.5 million deaths directly caused by diabetes, as per WHO
Two out of three people under the age of 40 are at risk of prediabetes
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)